Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Background The majority of studies assessing executive function in attention deficit disorder (ADD) have shown deficits in attentional set shifting using either the Wisconsin card sorting task or the intra-dimensional/extra-dimensional set-shifting task (ID/ED). Damage to the prefrontal cortex in humans, primates, and rodents impairs extra-dimensional (ED) shifts. Noradrenergic depletion of the medial prefrontal cortex in rats is sufficient to impair attentional set shifting. Atomoxetine, a selective norepinephrine (NE) re-uptake inhibitor, is hypothesized to produce beneficial effects in patient with ADD by augmenting NE release in prefrontal cortex.Materials and methods We assessed the effects of systemic administration of atomoxetine (0.0, 0.1, 0.3, and 0.9 mg/kg/ml) in normal and noradrenergically lesioned (NE-LX) rats on attentional-set shifts. We replicated findings showing NE-LX rats are selectively impaired on the ED shifts but not reversals or other discriminations.Results Atomoxetine remediated the attentional set-shifting impairments in NE-LX rats but impaired ED performance of non-lesioned rats.Discussion Though atomoxetine is neurochemically selective, it is not wholly specific at doses >0.3 mg/kg. All doses of the drug were similar in their efficacy in reversing the ED deficit, but the effectiveness of the 0.1 mg/kg dose supports the hypothesis that increases in prefrontal NE alone are sufficient to improve attention in NE-LX rats. Moreover, the detrimental effects of the drug in non-lesioned rats support the hypothesis that optimal levels of NE in prefrontal cortex are critical to attentional set shifting with both supra- and sub-optimal levels producing attentional impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The serotonin and norepinephrine reuptake inhibitor atomoxetine was able to rescue the deficits in ED caused by deafferentiation”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Newman et al 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Newman et al., 2008
In the citing paper
“presumably by preventing reuptake of norepinephrine released from the residual intact adrenergic terminals (Newman et al 2008).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Newman et al 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · cited 2×
“Norepinehrine has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al.”
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · cited 1×
“It is hypothesized that increases in accumbens dopamine levels underlie the addictive properties of stimulants (Koob and LeMoal 1997), so decreasing the addiction liability may require compounds that produce minimal changes in subcortical dopamine.”
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 2×
“…in attention deficit disorder (ADD) while many studies support a role for dopaminergic dysfunction (Barkley 1997; Sagvolden and Sergeant 1998; Castellanos and Tannock 2002; Viggiano et al. 2004b), and recent data suggest that dysfunction in norepinephrine (NE) may also contribute to…”
Dissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 2×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement (Owen et al. 1991, 1993; Dias et al. 1996a, b; Birrell and Brown 2000).”
Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · cited 1×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement (Owen et al. 1991, 1993; Dias et al. 1996a, b; Birrell and Brown 2000).”
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 1×
“…has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al. 2007; Tait et al. 2007).”
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · cited 8×
“Though atomoxetine is highly selective for the NE transporter, the 0.6 mg/kg dose increases the levels of NE and dopamine in frontal cortex, and this simultaneous release may be necessary to show beneficial effects on response inhibition (Bymaster et al. 2002).”
InfluentialNeurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?
Sergeant, J. A., Geurts, H., & Oosterlaan, J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00430-2 · Cited by 784 · cited 1×
“In contrast to work in adults, Sergeant and colleagues showed that a majority of studies using tests of executive function consistently differentiated the performance of children with ADD from control subjects (Sergeant et al. 2002).”
Research works printed but not linked: 1
- Tait D, McGaughy J, Latimer MP, Brown V (2002) 192 IgG-saporin lesions of the cholinergic basal forebrain do not impair attentional set-shifting, but do increase latency to dig. Proceedings of the Society for Neuroscience, New Orleans, LA
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
“Thus, doses of atomoxetine that impair attentional set shifting in normal rats appear to improve stop-signal performance (Newman et al. 2008).”
BackgroundLogue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
“In rats, lesions producing substantial decreases in mPFC NE impaired attention (Milstein et al. 2007) and set-shifting (McGaughy et al. 2008; Tait et al. 2007) and this deficit was reversed by the selective NE reuptake inhibitor, atomoxetine (Newman et al. 2008).”
BackgroundLearning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.01.007 · Cited by 398
“Results from the same laboratory extended these findings to the beneficial effects of atomoxetine, a NA reuptake inhibitor used for the treatment of attention deficit/hyperactivity disorder (ADHD), which at the low doses employed in that study only augments cortical NA [44 ].”
ResultArnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
Background
Metadata
- Authors
- Newman, L. A., Darling, J., & McGaughy, J.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- McGaughy, Jill
- Venue
- Psychopharmacology
- Published
- 2008-06-22
- Volume
- 200
- Issue
- 1
- Pages
- 39-50
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC10719959
- OpenAlex
- W2034057430
- Cited by
- 137
- References
- 77
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 8
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R21MH087921)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- atomoxetine, medial prefrontal cortex, set-shifting, norepinephrine reuptake inhibition, attention deficit disorder, executive function, dose-dependent effects
- MeSH terms
- Atomoxetine Hydrochloride, Animals, Attention, Attention Deficit Disorder with Hyperactivity, Behavior, Animal, Discrimination Learning, Disease Models, Animal, Dose-Response Relationship, Drug, Norepinephrine, Propylamines, Psychomotor Performance, Prefrontal Cortex, Adrenergic Uptake Inhibitors, Rats, Long-Evans, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. https://app.cochat.ai/papers/10.1007/s00213-008-1097-8
- The paper
- Newman, L. A., Darling, J., & McGaughy, J. (2008). Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. Psychopharmacology. https://doi.org/10.1007/s00213-008-1097-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.